Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA

Anti-amyloid therapies (AATs), such as anti-amyloid monoclonal antibodies, are emerging treatments for people with early Alzheimer’s disease (AD). AATs target amyloid β plaques in the brain. Amyloid-related imaging abnormalities (ARIA), abnormal signals seen on magnetic resonance imaging (MRI) of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sin, Mo-Kyung, Zamrini, Edward, Ahmed, Ali, Nho, Kwangsik, Hajjar, Ihab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647766/
https://www.ncbi.nlm.nih.gov/pubmed/37959255
http://dx.doi.org/10.3390/jcm12216792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647766/
https://www.ncbi.nlm.nih.gov/pubmed/37959255
http://dx.doi.org/10.3390/jcm12216792

Ejemplares similares